Connect to other sites within the UBM Medica Network
Freelance science writer and frequent Cancer Network and OncoTherapy Network contributor.
Follow Her on Twitter
Protecting Ovary Function During Breast Cancer Chemotherapy
The risk of early, sudden-onset menopause in women treated for early-stage breast cancer can be reduced with goserelin, a gonadotropin-releasing hormone agonist.
Patient Factors Linked With Ibrutinib Discontinuation
Researchers have identified patient factors linked with the discontinuation of ibrutinib therapy for reasons other than disease progression.
Two Clinical Factors May Predict PSA Response to Cabazitaxel
Two clinical factors may predict PSA response to cabazitaxel in men with metastatic castration-resistant prostate cancer.
Study Confirms 4Kscore Accurately Predicts High-Grade Prostate Cancer
The 4Kscore blood test has been shown to accurately detect the presence of high-grade prostate cancer, according to a study presented at ASCO GU.
Top 6 Highlights From the 2015 ASCO GU Cancers Symposium
This slide show includes some of the top highlights from the 2015 ASCO Genitourinary Cancers Symposium, including a study that examined the risk of aggressive prostate cancer in testicular cancer survivors and more.
Surveillance Risky in Intermediate-Risk Prostate Cancer?
Intermediate-risk prostate cancer patients managed with surveillance had worse outcomes compared with low-risk prostate cancer patients managed with surveillance.
High-Dose Radiotherapy Fails to Improve Prostate Cancer Survival
High-dose radiation therapy did not improve overall survival compared with the standard dose in stage II localized prostate cancer, but did show some benefits.
Hormone Therapy Adherence in Breast Cancer Linked to Race, Income
Economic factors, including household income, and racial disparities both play a role in the adherence to hormonal therapy in breast cancer patients.
Higher-Risk Prostate Cancer on the Rise?
A large retrospective analysis suggests the number of patients diagnosed with intermediate- and high-risk prostate cancer has increased since 2011.
Cancer Patients Rarely Request Unnecessary Testing
A new study suggests that cancer patients do not often request unnecessary and sometimes costly tests or treatments.
By clicking Accept, you agree to become a member of the UBM Medica Community.